These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12905814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Erythroid differentiation denucleation factor: a family of erythroid regulators for mammalian erythroid terminal differentiation/tumor suppression and the cloning of their related genes].
    Xue S, Liu Y, Zhang S, Ma W, Wang X, Fei R, Du Q, Zhang Z, Zhang J, Chen K, Zhou J, Ma J, Han D.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):371-5. PubMed ID: 12903454
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Factors controlling the differentiation and cancerization of murine erythroleukemia cells].
    Obinata M.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1989-95. PubMed ID: 3475040
    [Abstract] [Full Text] [Related]

  • 13. Induced erythroleukemia differentiation: cellular and molecular aspects.
    Rifkind RA, Sheffery M, Marks PA.
    Blood Cells; 1987 Jun; 13(1-2):277-84. PubMed ID: 3311222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV, Kukowska J.
    Nature; 1987 Jun; 322(6082):848-50. PubMed ID: 3528863
    [Abstract] [Full Text] [Related]

  • 18. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.
    Hensold JO, Barth D, Stratton CA.
    J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904
    [Abstract] [Full Text] [Related]

  • 19. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K, Kaku K, Seguchi M, Tanaka H, Azuno Y, Kaneko T.
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [Abstract] [Full Text] [Related]

  • 20. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y, Chen N, Yu HJ, Dong XP, Huang QH.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):544-8. PubMed ID: 16681885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.